EVQLV Archives - AI Insider

Ono Enters into Collaboration Agreement with EVQLV to Generate Novel Antibodies against Multiple Targets Utilizing EVQLV’s AI-powered Antibody Design Engine for Development of Innovative Antibody Drugs

Insider Brief Ono Pharmaceutical Co., Ltd. has partnered with EVQLV, INC for a discovery collaboration to generate novel antibodies for multiple therapeutic targets, utilizing EVQLV’s AI-powered Antibody Design Engine. This collaboration aims to accelerate

2 Jan 2024 · 3 min read

EVQLV

Ono Enters into Collaboration Agreement with EVQLV to Generate Novel Antibodies against Multiple Targets Utilizing EVQLV’s AI-powered Antibody Design Engine for Development of Innovative Antibody Drugs

Trending today

Study Finds Grok and GPT Models Show Opposing Partisan Leans on U.S. Midterm Races

Tractian Closes $130M Series D to Expand AI for Industrial Asset Health

Chinese Hackers Use AI Agents to Breach Thousands of Companies via ConnectWise

Nebius Secures $3.5B Citi Facility to Expand AI Cloud Capacity

France Sets 2027 Autonomous Vehicle Approval Path as Stellantis, Wayve, Bolt and G7 Pitch Pilots

EVQLV

Ono Enters into Collaboration Agreement with EVQLV to Generate Novel Antibodies against Multiple Targets Utilizing EVQLV’s AI-powered Antibody Design Engine for Development of Innovative Antibody Drugs

Trending today

Study Finds Grok and GPT Models Show Opposing Partisan Leans on U.S. Midterm Races

Tractian Closes $130M Series D to Expand AI for Industrial Asset Health

Chinese Hackers Use AI Agents to Breach Thousands of Companies via ConnectWise

Nebius Secures $3.5B Citi Facility to Expand AI Cloud Capacity

France Sets 2027 Autonomous Vehicle Approval Path as Stellantis, Wayve, Bolt and G7 Pitch Pilots

The AI economy, every weekday morning